lung cancer
| 3 min read
Scientists created a novel platform that uses the advantages of both bacteria and viruses to attack tumors.
| 5 min read
Highlights from AACR 2025, COVID-19 vaccine flip flops, an FDA approval for a rare skin disorder, and more led biotech and pharma news this week.
| 6 min read
By removing immunosuppressive factors from the blood, researchers hope to give the immune system a fighting chance against advanced tumors.
| 5 min read
A young cancer researcher made a big splash when she discovered that inhibiting DNA damage response proteins sensitizes treatment-resistant lung cancer cells to immunotherapy.
Page 1 of 1 - 4 Total Items
